Hacker News new | ask | show | jobs
by pgcudahy 1113 days ago
To get full approval they could combine this with animal efficacy studies like they did for the smallpox treatment tecoviromat, since you can’t give smallpox to trial participants either. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663070/

It turned out to be really useful to have tecoviromat for the recent mpox outbreak